Article Details

BioVaxys Prepares for Groundbreaking Study on reduced ACE2 binding capabilities of ...

Retrieved on: 2021-09-23 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

BioVaxys Prepares for Groundbreaking Study on reduced ACE2 binding capabilities of .... View article details on HISWAI: https://www.prnewswire.com/news-releases/biovaxys-prepares-for-groundbreaking-study-on-reduced-ace2-binding-capabilities-of-hapten-modified-sars-cov-2-proteins-301383613.html

Excerpt

VANCOUVER, BC, Sept. 23, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that it ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up